Interleukin-10 abrogates the inhibition of Epstein-Barr virus-induced B- cell transformation by memory T-cell responses

Blood

Volumn 92, Issue 11, 1998, Pages 4256-4262

  Bejarano, M T ^a,b   Masucci, M G ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNOLOGICAL MEMORY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFORMATION; MEMORY CELL; PRIORITY JOURNAL;

EID: 0032400864     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.11.4256.423k12_4256_4262     Document Type: Article

References (47)

1. Moore KW, Vieira P, Fiorentino DF, Trounstine ML, Khan TA, Mossman TR: Homology of the cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRF1. Science 248:1230, 1990
2. Vieira P, de Waal Malefyt R, Dang MN, Johnson KE, Kastelein R, Fiorentino DF, de Vries JE, Roncarolo MG, Mosmann TR, Moore KW: Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: Homology to Epstein-Barr virus open reading frame BCRF1. Proc Natl Acad Sci USA 88:1172, 1991
3. Burdin N, Rousett F, Banchereau J: B cell-derived IL-10: Production and function. Methods 11:98, 1997
4. Fluckiger AC, Durand I, Banchereau J: Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells. J Exp Med 179:91, 1994
5. Levy Y, Brouet JC: Interleukin-10 prevents spontaneous death of germinal center B cells by induction of Bcl-2 protein. J Clin Invest 93:424, 1994
6. + T cell clones and peripheral blood T cells. J Immunol 149:2378, 1992
7. de Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE: Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174:915, 1991
8. Bejarano MT, de Waal Malefyt R, Abrams JS, Bigler M, Bacchetta R, de Vries JE, Roncarolo MG: Interleukin 10 inhibits allogeneic proliferative and cytotoxic T cell responses generated in primary mixed lymphocyte cultures. Int Immunol 4:1389, 1992
9. Macatonia SE, Doherty TM, Knight SC, O'Garra A: Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production. J Immunol 150:3755, 1993
10. Caux C, Massacrier C, Vanbervliet C, Barthelemy C, Liu YJ, Banchereau J: Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells. Int Immunol 6:1177, 1994
11. + T cell clones and resting T cells. J Immunol 150:4754, 1993
12. Taga K, Mostowski H, Tosato G: Human interleukin-10 can directly inhibit T cell growth. Blood 81:2964, 1993
13. + T cells. J Exp Med 184:19, 1996
14. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737, 1997
15. Rickinson AB, Kieff E: Epstein-Barr virus, in Fields BM, Knipe DM, Howley PM (eds): Fields Virology. Philadelphia, PA, Lippincott, 1996, p 2397
16. Benjamin D, Knobloch TJ, Dayton MA: Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10. Blood 80:1289, 1992
17. Finke J, Termes P, Lange W, Mertelsmann R, Dölken G: Expression of interleukin 10 in B lymphocytes of different origin. Leukemia 7:1852, 1993
18. Stewart JP, Behm FG, Arrand JR, Rooney CM: Differential expression of viral and human interleukin-10 (IL-10) by primary B cell tumors and B cell lines. Virology 200:724, 1994
19. + T lymphocytes. Int J Cancer 62:5, 1995
20. Baiocchi R, Ross ME, Tan JC, Chou CC, Sullivan L, Haldar S, Monne M, Seiden MV, Narula SK, Sklart J, Croce C, Caligiuri MA: Lymphomagenesis in the SCID-hu mouse involves abundant production of IL-10. Blood 85:1063, 1995
21. Moss DJ, Rickinson AB, Pope JH: Long term T-cell mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes. Int J Cancer 22:662, 1978
22. Masucci MG, Bejarano MT, Masucci G, Klein E: Large granular lymphocytes inhibit the in vitro growth of autologous Epstein-Barr virus-infected B cells. Cell Immunol 76:311, 1983
23. Julius MH, Simpson N, Herzenberg LA: Rapid method for isolation of functional T lymphocytes. Eur J Immunol 3:645, 1973
24. Bejarano MT, Torsteinsdottir S, Andersson JP, Andersson UG, Masucci MG, Szigeti R, Klein E, Klein G: Defective cell-mediated response to EBV-transformed B cells in a healthy individual with regular EBV antibody titers. Int J Cancer 40:149, 1987
25. Burdin N, Pérone C, Banchereau J, Rousset F: Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10. J Exp Med 177:295, 1993
26. Stuart AD, Stewart JR Arrand JR, Mackett M: The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes. Oncogene 11:1711, 1995
27. Beatty PR, Krams SM, Martinez O: Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines. J Immunol 158:4045, 1997
28. Bejarano MT, Masucci MG, Ernberg I, Klein E, Klein G: Effect of Cyclosporin-A (CsA) on the ability of T lymphocyte subsets to inhibit the proliferation of autologous EBV-transtormed B cells. Int J Cancer 35:327, 1985
29. Fiorentino DP, Bond MW, Mossmann TR: Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by TH1 clones. J Exp Med 170:2081, 1989
30. Crawford DH, Iliescu V, Edwards AI, Beverley PC: Characterization of Epstein-Barr virus-specific memory T cells from the peripheral blood of seropositive individuals. Br J Cancer 47:681, 1983
31. Miyazaki I, Chewung RK, Dosch HM: Viral interleukin-10 is critical for the induction of B cell growth transformation by Epstein-Barr virus. J Exp Med 178:439, 1993
32. Nakagomi H, Dolcetti R, Bejarano MT, Pisa P, Kiessling R, Masucci MG: The Epstein-Barr virus latent membrane protein-1 (LMP-1) induces interleukin-10 production in Burkitt lymphoma cell lines. Int J Cancer 57:240, 1994
33. Hasler F, Bluestein HG, Zvaifler NJ, Epstein LB: Analysis of the defects responsible for the impaired regulation of Epstein-Barr virus-induced B cell proliferation by rheumatoid arthritis lymphocytes. J Exp Med 157:173, 1983
34. Swaminathan S, Hesselton R, Sullivan J, Kieff E: Epstein-Barr virus recombinants with specifically mutated BCRF1 genes. J Virol 97:7406, 1993
35. Zeidler R, Eissner G, Meissner P, Uebel S, Tampé R, Lazis S, Hammerschmidt W: Downregulation of TAP1 in B lymphocytes by cellular and Epstein-Barr virus-encoded interleukin-10. Blood 90:2390, 1997
36. Früh K, Ahn K, Peterson PA: Inhibition of MHC class I antigen presentation by viral proteins. J Mol Med 75:18, 1997
37. Hill A, Jugovic P, York I, Rus G, Bennink J, Yewdell J, Ploegh H, Johnson D: Herpes simplex virus turns off the TAP to evade host immunity. Nature 375:411, 1995
38. Früh K, Ahn K, Djaballah H, Sempé P, van Endert PM, Tampé R, Peterson PA, Yang Y: A viral inhibitor of peptide transporters for antigen presentation. Nature 375:415, 1995
39. Ahn K, Angulo A, Ghazal P, Peterson PA, Yang Y, Früh K: Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc Natl Acad Sci USA 93:10990, 1996
40. Ahn K, Gruhler A, Galocha B, Jones TR, Wiertz EJHJ, Ploegh H, Peterson PA, Yang Y, Früh K: The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6:613, 1997
41. Levitskaya J, Shapiro A, Leonchiks A, Chiecanover A, Masucci MG: Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen-1. Proc Natl Acad Sci USA 94:12616, 1997
42. Spriggs MK, Armitage RJ, Comeau MR, Strockbine L, Farrah T, Macduff B, Ulrich Dawn, Alderson MR, Müllberg J, Cohen JI: The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR β chain and inhibits antigen presentation. J Virol 70:5557, 1996
43. Stewart JP, Rooney CM: The interleukin-10 homolog encoded by Epstein-Barr virus enhances the reactivation of virus-specific cytotoxic T cell and HLA-unrestricted killer cell responses. Virology 191:773, 1992
44. Bogedain C, Wolf H, Modrow S, Stuber G, Jilg W: Specific cytotoxic T-lymphocytes recognize the immediate-early transactivator ZTA of Epstein-Barr virus. J Virol 69:4872, 1995
45. Steven NM, Annels NE, Kumar A, Leese AM, Kurilla MG, Rickinson AB: Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response. J Exp Med 185:1605, 1997
46. Taga K, Chretien J, Cherney B, Diaz L, Brown M, Tosato G: Interleukin-10 inhibits apoptotic cell death in infectious mononucleosis T cells. J Clin Invest 94:251, 1994
47. Frisan T, Sjöberg J, Dolcetti R, Boiocchi M, De Re A, Carbone A, Brautbar C, Battat S, Biberfeld P, Eckman M, Öst A, Christensson B, Sundström C, Björkholm M, Pisa P, Masucci MG: Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease. Blood 86:1493, 1995